rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-1-30
|
pubmed:abstractText |
Acid suppression is the mainstay of therapy in gastro-oesophageal reflux disease. Esomeprazole 40 mg is more effective than lansoprazole 30 mg in healing mucosal lesions in severe erosive reflux oesophagitis. However, data comparing esomeprazole with lansoprazole in patients with complications of gastro-oesophageal reflux disease, such as ulcerative reflux oesophagitis and Barrett's oesophagus, are lacking.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1590-8658
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
85-90
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16289976-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:16289976-Anti-Ulcer Agents,
pubmed-meshheading:16289976-Barrett Esophagus,
pubmed-meshheading:16289976-Esophagitis, Peptic,
pubmed-meshheading:16289976-Esophagus,
pubmed-meshheading:16289976-Female,
pubmed-meshheading:16289976-Gastric Acid,
pubmed-meshheading:16289976-Gastroesophageal Reflux,
pubmed-meshheading:16289976-Humans,
pubmed-meshheading:16289976-Hydrogen-Ion Concentration,
pubmed-meshheading:16289976-Male,
pubmed-meshheading:16289976-Manometry,
pubmed-meshheading:16289976-Middle Aged,
pubmed-meshheading:16289976-Omeprazole,
pubmed-meshheading:16289976-Prospective Studies,
pubmed-meshheading:16289976-Proton Pumps
|
pubmed:year |
2006
|
pubmed:articleTitle |
Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
|
pubmed:affiliation |
Internal Medicine and Gastroenterology Unit, New S. Agostino Hospital, Via Martignana 51, Modena 41100, Italy. m.frazzoni@ausl.mo.it
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|